Is your takadaism - run for the hills as shire destroys the US business ? Phlegm way overpromised and Takadive way overpaid. Have you realised that YOU will pay the price ? There is nothing to sell at Shire that can possibly make up for the gigantic enormous massive check that Takadive just wrote. After the close the new corporate mission will be call "cost control" "realignment" "synergy" "RIF"... OUCH Great deal *cough* *cough* ewww my hand is covered in phlegm
yea..all the bankers and financial advisors are a bunch of nimrods who don't have a clue about Shire's pipeline and potential profit..Why didn't they defer to YOU?
That’s a great point. That same group really helped Allergan, Endo, Mallinkrodt, Valeant etc. Maybe learn some facts before you start yapping.
Takeda - you need to wake up and see what is on the horizon with Shire. The company is not worth the amount offered and the CEO is driving it down to the ground. Lots of great people leaving. I would hate to say "I told you so"! PLEASE look at Shire before we make the decision. PRETTY PLEASE!!!!!
No, they should have deferred to Warren Buffet, the greatest investor of all time. Here is what he said about this type of situation in his annual letter, published earlier this year: "Indeed, price seemed almost irrelevant to an army of optimistic purchasers. Why the purchasing frenzy? In part, it's because the CEO job self-selects for 'can-do' types. If Wall Street analysts or board members urge that brand of CEO to consider possible acquisitions, it's a bit like telling your ripening teenager to be sure to have a normal sex life. Once a CEO hungers for a deal, he or she will never lack for forecasts that justify the purchase. Subordinates will be cheering, envisioning enlarged domains and the compensation levels that typically increase with corporate size. Investment bankers, smelling huge fees, will be applauding as well. (Don't ask the barber whether you need a haircut.) If the historical performance of the target falls short of validating its acquisition, large 'synergies' will be forecast. Spreadsheets never disappoint."
